EP1444250A4 - GROEL CHIMERIC PROTEIN AND VACCINE - Google Patents

GROEL CHIMERIC PROTEIN AND VACCINE

Info

Publication number
EP1444250A4
EP1444250A4 EP02776592A EP02776592A EP1444250A4 EP 1444250 A4 EP1444250 A4 EP 1444250A4 EP 02776592 A EP02776592 A EP 02776592A EP 02776592 A EP02776592 A EP 02776592A EP 1444250 A4 EP1444250 A4 EP 1444250A4
Authority
EP
European Patent Office
Prior art keywords
groel
vaccine
chimeric protein
chimeric
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02776592A
Other languages
German (de)
French (fr)
Other versions
EP1444250A1 (en
Inventor
Thiru Vanniasinkam
Mary Barton
Micahel W Heuzenroeder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medvet Science Pty Ltd
Rural Industries Research and Development Corp
Adelaide University
Original Assignee
Medvet Science Pty Ltd
University of South Australia
Rural Industries Research and Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medvet Science Pty Ltd, University of South Australia, Rural Industries Research and Development Corp filed Critical Medvet Science Pty Ltd
Publication of EP1444250A1 publication Critical patent/EP1444250A1/en
Publication of EP1444250A4 publication Critical patent/EP1444250A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1285—Gram-positive bacteria from Corynebacterium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
EP02776592A 2001-10-26 2002-10-25 GROEL CHIMERIC PROTEIN AND VACCINE Withdrawn EP1444250A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPR852301 2001-10-26
AUPR8523A AUPR852301A0 (en) 2001-10-26 2001-10-26 Groel chimeric protein and vaccine
PCT/AU2002/001460 WO2003035676A1 (en) 2001-10-26 2002-10-25 Groel chimeric protein and vaccine

Publications (2)

Publication Number Publication Date
EP1444250A1 EP1444250A1 (en) 2004-08-11
EP1444250A4 true EP1444250A4 (en) 2006-03-08

Family

ID=3832345

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02776592A Withdrawn EP1444250A4 (en) 2001-10-26 2002-10-25 GROEL CHIMERIC PROTEIN AND VACCINE

Country Status (6)

Country Link
US (1) US20050063984A1 (en)
EP (1) EP1444250A4 (en)
JP (1) JP2005515759A (en)
AU (1) AUPR852301A0 (en)
NZ (1) NZ532070A (en)
WO (1) WO2003035676A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2583361C (en) * 2004-10-15 2015-08-04 Sekisui Chemical Co., Ltd. Gene immunization using an antigen-chaperonin fusion
KR100959696B1 (en) * 2008-01-23 2010-05-26 경상대학교산학협력단 Fusion protein expression vector and its preparation method for protein epitope analysis of Helicobacter pylori

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109790A0 (en) * 1994-05-25 1994-08-26 Yeda Res & Dev Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines
CA2125426A1 (en) * 1994-06-08 1995-12-09 University Of Guelph Rhodococcus equi gene sequence
CA2298558A1 (en) * 1997-07-28 1999-02-04 Temple University - Of The Commonwealth System Of Higher Education Genetically engineered rhodococcus vaccine
JP4249832B2 (en) * 1998-12-28 2009-04-08 タカラバイオ株式会社 Trigger factor expression plasmid
AUPQ712000A0 (en) * 2000-04-27 2000-05-18 Medvet Science Pty. Ltd. Antigenic peptide fragments of VapA protein, and uses thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
HEUZENROEDER ET AL.: "Development of diagnostic tests and vaccines for Rhodococcus equi infection", August 2003 (2003-08-01), pages 1 - 35, XP002362946, Retrieved from the Internet <URL:http://www.rirdc.gov.au/reports/HOR/03-096.pdf> [retrieved on 20060116] *
See also references of WO03035676A1 *
VANNIASINKAM T ET AL: "Immune response to vaccines based upon the VapA protein of the horse pathogen, Rhodococcus equi, in a murine model", INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, URBAN UND FISCHER, DE, vol. 294, no. 7, 26 January 2005 (2005-01-26), pages 437 - 445, XP004960178, ISSN: 1438-4221 *
VANNIASINKAM THIRU ET AL: "The immunogenicity of Rhodococcus equi GroEL2-based vaccines in a murine model.", VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, vol. 98, no. 1-2, March 2004 (2004-03-01), pages 91 - 100, XP002362947, ISSN: 0165-2427 *

Also Published As

Publication number Publication date
JP2005515759A (en) 2005-06-02
AUPR852301A0 (en) 2001-11-29
NZ532070A (en) 2008-04-30
WO2003035676A1 (en) 2003-05-01
EP1444250A1 (en) 2004-08-11
US20050063984A1 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
ATE480567T1 (en) HIGHLY CONCENTRATED ANTIBODIES AND PROTEIN FORMULATIONS
IS7499A (en) Human antibodies against beta-amyloid peptides
IS6779A (en) Human antibody against LT-beta-R
EE200300528A (en) Cripto protein blocking antibodies and their use
EP1529054A4 (en) THERAPEUTIC PROTEIN AND TREATMENTS
CY2009014I1 (en) VACCINE AGAINST BACTERIAL ANTIGENS
NO20011964D0 (en) Well treatment fluids and methods using them
NO20044192L (en) 17alpha-alkyl-17beta-oxy-ostratrienes and pharmaceutical preparations
EP1412378A4 (en) APTAMERES AND ANTIAPTAMERS
DK1228217T3 (en) Preserved Neisseria Antigens
NO20033418L (en) Immune regulatory antibodies and their use
EP1423141A4 (en) VACCINE
DK1427444T3 (en) WEST-NIL VACCINE
DZ3219A1 (en) VACCINE
EP1460900A4 (en) SEPARATE HUMAN PROTEINS
NO20033882D0 (en) Vaccine
EP1450752A4 (en) MULTIVALENT STREPTOCOCCULAR VACCINE COMPOSITIONS AND APPLICATION METHODS
NO20040249L (en) Blood group antigen fusion polypeptides and methods for their use
DK1381382T3 (en) Methods and Preparations for the Treatment of Eye Diseases
NO20033506D0 (en) Parasite-killing preparations and methods of use
DE60232967D1 (en) OKULAR TISSUE GROWTH FACTOR-SIMILAR PROTEIN
DE60226057D1 (en) POULTRY ILLNESSIBLE BACTERIUM AND DERIVED VACCINE
EP1444250A4 (en) GROEL CHIMERIC PROTEIN AND VACCINE
ITMI20001987A0 (en) VARIANTS OF ALLERGENIC PHLEUM PRATENSE PROTEINS
ATE368115T1 (en) BACTERIAL INSECTICIDE PROTEINS

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040423

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1068635

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20060125

17Q First examination report despatched

Effective date: 20080121

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100409

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1068635

Country of ref document: HK